In the treatment of cancer, SKF-96365, a SOCE/Orai1 blocker, has been shown to impair cell proliferation of GBM cells in vitro [256] and metastasis of breast cancer cells in vivo [295]. This evidence concerns the gene ORAI1 and breast carcinoma.